Noara Therapeutics

Pioneering the 3rd Generation of Therapeutic RNAs, Powered by Machine Intelligence

Our Mission

To revolutionize human health by unlocking the full potential of RNA therapeutics through our groundbreaking technology

The Problem

Current RNA modalities face major limitations: mRNAs are inherently unstable, while circular and self-amplifying RNAs tend to be immunogenic and difficult to manufacture — confining their use primarily to vaccines for infectious diseases and select cancers.

The Solution

Our proprietary platform, MITREN (Machine Intelligence-guided Therapeutic RNA Engineering), enables the design, creation, and high-throughput screening of a novel RNA modality that is immunosilent, active, and exceptionally stable.

The Team

A multidisciplinary team of experts in RNA medicine, machine intelligence, metabolic disease, and RNA biology.